Diana T McCloskey, Sally Turcato, Guan-Ying Wang, Lynne Turnbull, Bo-Qing Zhu, Thomas Bambino, Anita P Nguyen, David H Lovett, Robert A Nissenson, Joel S Karliner, Anthony J Baker
Index: Am. J. Physiol. Heart Circ. Physiol. 294(1) , H205-12, (2008)
Full Text: HTML
Increased signaling by G(i)-coupled receptors has been implicated in dilated cardiomyopathy. To investigate the mechanisms, we used transgenic mice that develop dilated cardiomyopathy after conditional expression of a cardiac-targeted G(i)-coupled receptor (Ro1). Activation of G(i) signaling by the Ro1 agonist spiradoline caused decreased cellular cAMP levels and bradycardia in Langendorff-perfused hearts. However, acute termination of Ro1 signaling with the antagonist nor-binaltorphimine did not reverse the Ro1-induced contractile dysfunction, indicating that Ro1 cardiomyopathy was not due to acute effects of receptor signaling. Early after initiation of Ro1 expression, there was a 40% reduction in the abundance of the sarcoplasmic reticulum Ca(2+)-ATPase (P < 0.05); thereafter, there was progressive impairment of both Ca(2+) handling and force development assessed with ventricular trabeculae. Six weeks after initiation of Ro1 expression, systolic Ca(2+) concentration was reduced to 0.61 +/- 0.08 vs. 0.91 +/- 0.07 microM for control (n = 6-8; P < 0.05), diastolic Ca(2+) concentration was elevated to 0.41 +/- 0.07 vs. 0.23 +/- 0.06 microM for control (n = 6-8; P < 0.01), and the decline phase of the Ca(2+) transient (time from peak to 50% decline) was slowed to 0.25 +/- 0.02 s vs. 0.13 +/- 0.02 s for control (n = 6-8; P < 0.01). Early after initiation of Ro1 expression, there was a ninefold elevation of matrix metalloproteinase-2 (P < 0.01), which is known to cause myofilament injury. Consistent with this, 6 wk after initiation of Ro1 expression, Ca(2+)-saturated myofilament force in skinned trabeculae was reduced to 21 +/- 2 vs. 38 +/- 0.1 mN/mm(2) for controls (n = 3; P < 0.01). Furthermore, electron micrographs revealed extensive myofilament damage. These findings may have implications for some forms of human heart failure in which increased activity of G(i)-coupled receptors leads to impaired Ca(2+) handling and myofilament injury, contributing to impaired ventricular pump function and heart failure.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
U-62066
CAS:87151-85-7 |
C22H30Cl2N2O2 |
Early role of the κ opioid receptor in ethanol-induced reinf...
2012-03-20 [Physiol. Behav. 105(5) , 1231-41, (2012)] |
Characterization of intraocular pressure responses of the Ti...
2011-01-01 [Mol. Vis. 17 , 1405-13, (2011)] |
Pharmacological characterization of 2-methyl-N-((2'-(pyrroli...
2011-11-01 [J. Pharmacol. Exp. Ther. 339 , 555-566, (2011)] |
Effect of kappa-opioid receptor agonists U69593, U50488H, sp...
2009-01-01 [Pharmacol. Biochem. Behav. 94(2) , 244-9, (2009)] |
Sensitivity to the effects of a kappa opioid in rats with fr...
2004-01-01 [Pharmacol. Biochem. Behav. 77(1) , 49-57, (2004)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved